FDA Fully Approves First Drug Meant to Slow Alzheimer's Disease | Smart News

The drug showed promise in an 18-month clinical trial, but some experts have expressed concerns about its safety and cost

Related Keywords

Washington ,District Of Columbia ,United States ,New York ,Americans ,Alberto Espay ,Laurie Mcginley ,Jason Karlawish ,Nadia Kounang ,Tami Luhby ,Ronald Petersen ,Teresa Buracchio ,Meg Tirrell ,Berkeley Lovelace Jr ,Joanne Pike ,Timespam Belluck ,Washington Post ,Drug Administration ,University Of Pennsylvania Penn Memory Center ,Alzheimer Association ,Office Of Neuroscience ,University Of Cincinnati ,Cnn ,New York Times ,Drug Evaluation ,Mayo Clinic ,Berkeley Lovelace ,New England Journal ,Penn Memory Center ,New York Times Pam ,Inside Science ,